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Abstract 
AIM: The present study aims to assess the therapeutic effect of the combination of topical ozone and steroid 
therapy in comparison to topical ozone alone versus topical steroid as a control in the management of atrophic - 
erosive oral lichen planus (OLP). 
METHODS: Sixty-six patients are having atrophic-erosive OLP were included in the study. They were randomly 
divided into three equal groups to be treated with topical corticosteroids alone (steroid group) as control, topical 
ozone alone (ozone group) or combination of topical steroids and ozone (combined group). Assessment of pain 
and sign scores was done before and after each treatment modality. 
RESULTS: The results revealed that the greatest significant percentage of change and subsequent improvement 
in pain and sign scores were recorded in the combined group. 
CONCLUSION: Reported data in this study using the combination of ozone and steroid therapy could provide a 
new promising safe and effective adjunct therapy for management of OLP. 
 
 
 
 
 
 
 
 
 
 
Introduction 
 
Lichen planus is a common chronic 
mucocutaneous disorder of uncertain cause. It has 
been reported that it involved about 0.5% to 2.2% of 
the examined populations worldwide [1]. 
Oral lichen planus (OLP) can be seen 
commonly in the fifth and sixth decades of life with a 
twice predominance in females as compared to males 
[2] [3]. The exact aetiology and pathogenesis of OLP 
are undetermined including a cell-mediated immune 
response associated with degeneration of the basal 
cell layer of the epithelium [4]. Six clinical forms of 
OLP lesions are recognised divided into two essential 
categories either white keratotic (plaque-like, papular, 
reticular) or white keratotic with red areas (bullous, 
erosive, atrophic) [5]. Keratotic lesions are 
asymptomatic with no need of treatment. Meanwhile, 
red sores are painful and require treatment, in addition 
to their potential and risk for malignant changes to 
squamous cell carcinoma mostly occurring in 0.4-2% 
of cases which should be taken into consideration [6]. 
OLP is generally observed bilaterally or symmetrically 
on the buccal mucosa, less regular on the tongue, 
labial mucosa and gingiva [7]. 
Multiple and various therapeutic approaches 
have been discussed in the management of OLP. As 
there is an alteration in disease activity, the use of a 
sole and definitive therapeutic modality is challenging. 
Existing treatment modalities are chiefly concerned 
with the improvement of the painful symptoms and 
mucosal ulcerations. The available therapies are still 
unable to cure the disease completely because of its 
refractory nature. Various available treatment options 
for management of OLP include topical and systemic 
agents. Intralesional and systemic corticosteroids are 
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mainly utilised yet with frequently unsatisfactory 
outcomes [8].  
Corticosteroids still considered the main 
treatment for symptomatic OLP; however, its 
prolonged use revealed several adverse effects 
including atrophy of mucosal tissues with subsequent 
discomfort, candida overgrowth, adrenal suppression, 
hypertension, gastrointestinal upset and 
hyperglycemia. Efficient treatment option with minimal 
adverse effects still appears to be essential regarding 
the development of resistance to topical steroids with 
its inconveniences in some patients [9].  
Ozone therapy has gained a prominent 
consideration in the medical and dental fields due to 
its strong antimicrobial activity (against bacteria, 
viruses, yeasts and protozoa) and as a powerful 
oxidising agent. It is also capable of stimulating the 
blood circulation and the immune system with 
reported analgesic effect [10].  
Dental applications of ozone included 
prevention and management of dental caries, teeth 
remineralisation, control of infection, disinfection of 
periodontal pockets, teeth bleaching, management of 
pain accompanying exposed roots and tooth 
sensitivity, TMJ disorders, endodontic treatment, 
biofilm removal, enhancement of healing, tissue 
regeneration and control of halitosis. Ozone therapy is 
an alternative non-medication therapy that has also 
been introduced as a treatment option in the 
management of OLP [11].  
Accordingly, this study aimed to evaluate the 
therapeutic effect of the combination of topical ozone 
and steroid in comparison to topical ozone alone and 
topical steroids as a control in the management of 
atrophic-erosive OLP. 
 
 
Patients and Methods 
 
This randomised controlled clinical study 
included sixty-six patients according to the sample 
size calculation with an age range between 30-70 
years.  
Power analysis for the 3 study groups were 
conducted in G* power to determine the sufficient 
sample size using an alpha of 0.05, a power of 0.80, 
and large effect size (f = 0.40). Based on the 
assumptions above, the desired sample size was 66 
patients. 
Patients were recruited from the outpatient 
clinic of the Oral Medicine and Periodontology 
Department, Faculty of Dentistry, Cairo University and 
from the outpatient clinic of the Skin and Venereal 
Diseases Department, Faculty of Medicine, Cairo 
University. 
The study protocol was approved by the 
Medical Ethical Committee of the National Research 
Centre (NRC) code no. 17 115. After the study 
procedures were explained before starting the 
treatment to the patients, they all signed an informed 
consent form stating their approval. This contemplates 
conducted on atrophic-erosive OLP patients affecting 
the tongue or buccal mucosa. Diagnosis of OLP 
Patients was based on the diagnostic steps criteria 
approved by the World Health Organization (WHO) 
[12]. 
Medical data were collected from the patients 
according to the Modified Cornel Medical Index 
questionnaire [13]. Smokers, pregnant or lactating 
ladies and patients under topical or systemic steroids 
during the last two months were excluded from the 
study. Patients using lichenoid reaction-inducing 
drugs, patients with positive hepatitis C virus (HCV) 
antibodies, those having systemic diseases that may 
contribute in the occurrence of OLP such as 
uncontrolled diabetes and hypertension were not 
allowed to participate in this study. Patients having 
amalgam filling adjacent lesions are also not included. 
All participants in the study groups underwent 
adequate oral hygiene performance measures with 
complete removal of plaque and calculus as they 
implement intraoral inflammation and intensify both 
extension and symptoms of OLP lesions. Patients 
were advised to evade accidental trauma on soft 
tissues using soft bristles toothbrush. Acidic, spicy, 
hard, hot food and beverages were avoided. 
The included 66 patients were randomly 
assigned, by preoperative envelope drawing, to be 
treated in the different study groups. The patients 
were divided into three equal groups. The steroid 
group (n = 22) as a control in which patients were 
treated by topical steroid alone. The ozone group (n = 
22) in which patients were treated with topical ozone 
alone. The combined group (n = 22) in which patients 
were treated with a combination of topical ozone and 
topical steroid therapy.  
Topical steroid therapy involved use of 
commercially available ointment (triamcinolone 
acetonide 0.1%, Kenacort-A Orabase
®
, Turkey) 
repeated four times per day for four weeks. Topical 
ozone therapy was done by using an ozone 
generator. Ozone generator type N 1888A, China was 
used in the application procedures of gaseous ozone 
with an ozone rate of 500 mg/hour. 
An ozone measuring device was used to 
confirm the ppm of ozone delivered and a flow meter 
was used to confirm the flow rate immediately before 
the start of the treatment. Ozone was applied on the 
lesions through special disposable glass cups that 
permitted adequate seal to avoid gas escape which 
ensured the safety of the machine for human use. No 
ozone could escape and therefore no ozone smell 
could be detected which allowed blinding. Ozone was 
applied intraoral with an intensity of 60% for 1 minute 
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according to the manufacturer instructions in each 
session twice a week for four weeks. Combined 
topical ozone and steroids therapy involved both 
topical ozone application (twice weekly) followed by 
topical steroid use (four times daily) for four weeks 
with at least 2 hours interval between topical ozone 
and steroid application in the day of ozone session as 
previously mentioned. All the patients in the three 
groups were followed up weekly during the four 
weeks. 
All cases in the three groups were assessed 
using the sign scoring scale of Thongprasom et al., 
1992 [14] as follows: 5 (white striae with an erosive 
area > 1 cm
2
), 4 (white striae with an erosive area < 1 
cm
2
), 3 (white striae with an atrophic area > 1 cm
2
), 2 
(white striae with an atrophic area < 1 cm
2
), 1 (mild 
white striae only), and 0 (no lesions, normal mucosa).  
Pain assessment for all cases of the study 
groups was done using grade of pain scale before, 
during and after different treatments according to 
Garnick et al., 1998 [15], as follows: grade 0 (no 
symptoms), grade 1 (mild discomfort and capable of 
eating), grade 2 (moderate discomfort but still capable 
of eating), grade 3 (severe discomfort and unable to 
eat), grade 4 (tolerated pain and unable to eat). 
Data were analysed by using SPSS ver. 18.0 
(SPSS Inc., Chicago, IL, USA). Descriptive statistics 
included mean, median, and standard deviation (SD) 
values. The paired t-test was used to compare sign 
scores at baseline and after the end of the treatment 
within the same group. Friedman test was used to 
evaluate the difference in the sign and pain scores of 
lesions throughout the study. The percentage of 
change was also calculated. Comparison of the 
percentage of change in the study groups was 
performed using one-way analysis of variance 
(ANOVA) test, followed by Tukey’s post hoc test for 
multiple comparison. Values of p < 0.05 was 
considered statistically significant. 
 
 
Results 
 
A total of 66 patients (39 female and 27 
males) having atrophic-erosive OLP having an age 
range from 30-70 years (mean 54.67 ± 4.63 years) 
were included in the study.  
In this contemplate topical ozone application 
alone and the combination of topical steroid and 
ozone did not cause any unwanted tissue reactions or 
complications. It was found that 3 cases in the steroid-
treated group complained from oral candidiasis. 
No statistically significant difference was 
shown between mean age values (p = 0.14) and 
gender distributions (p = 1) in the three groups as 
presented in Table 1). 
Table 1: Mean age values and gender distributions in the three study groups 
 Age  Gender 
Steroid Ozone Combined Steroid Ozone Combined 
Male Female Male Female Male Female 
Mean ± SD 56.2 ± 5.5 53.4 ± 4.2 54.4 ± 4.2 Number (%) 9 (40.9%) 13 (60.1%) 9 (40.9%) 13 (60.1%) 9 (40.9%) 13 (60.1%) 
F value 2.028 X
2
 0 
P (ANOVA) 0.140 ns P value (chi 
square) 
1 ns 
Significance level p < 0.05; * = significant; ns = non-significant. 
Within each group, sign scores decreased 
after treatment. Paired t test revealed that this 
difference was statistically significant in steroid (p = 
0.016), ozone (p = 0.0038) and combined group (p = 
0.0004), (Table 2, Figure 1). 
Table 2: Comparison of sign scores expressed as mean ± SD at 
baseline and after the end of treatment within the same group 
(paired t-test) 
Groups Before treatment After treatment t value P value 
Sign 
score 
Pain 
score 
Sign 
score 
Pain 
score 
Sign 
score 
Pain 
score 
Sign 
score 
Pain 
score 
Steroid 4.6±0.55 3.6±0.55 3.6±0.55 0.8±0.45 -0.4 -0.14 0.016* 0.0001* 
Ozone 4.2±1.1 3.4±0.89 3±1 2.8±0.45 -0.6 -2.45 0.0038* 0.07 ns 
Combined 4.2±0.84 3.2±0.84 1.6±0.44 0.6±0.15 -10.6 -10.6 0.0004* 0.0004* 
Significance level p<0.05; *=significant; ns=non-significant. 
 
Within each group, pain scores decreased 
after treatment. Paired t-test revealed that this 
difference was statistically significant in steroid (p = 
0.0001), and combined group (p = 0.0004). However, 
the difference between baseline and after treatment 
values of pain score in ozone group was not 
statistically significant (p = 0.07), (Table 2, Figure 1). 
 
 
Figure 1: Sign score and pain during the treatment 
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Table 3: Comparison of sign and pain scores t baseline and after 1, 2, 3 and 4 weeks within the same group (Friedman test) 
  Sign score Pain score 
Baseline After 1 w After 2 w After 3 w After 4 w Baseline After 1 w After 2 w After 3 w After 4 w 
Steroid 
 
Mean ± SD 4.6 ± 0.55 3.8 ± 0.84 3.4 ± 0.89 3.4 ± 0.89 3.6 ± 0.55 3.6 ± 0.55 2.8 ± 0.45 2.4 ± 0.89 2 ± 0.71 0.8 ± 0.45 
Median 5 4 4 4 4 4 3 3 2 1 
Min 4 3 2 2 3 3 2 1 1 0 
Max 5 5 4 4 4 4 3 3 3 1 
Mean rank 4.9 3.1 2.2 2.2 2.6 4.7 3.7 3.1 2.5 1 
P value Chi square = 96.38, P < 0.0001* Chi square = 106.6,  P < 0.0001* 
Ozone 
 
Mean ± SD 4.2 ± 1.1 4.2 ± 1.1 3.8 ± 0.84 3.2 ± 1.1 3 ± 1.0 3.4 ± 0.89 3.4 ± 0.89 3 ± 0.71 2.6 ± 0.55 2.8 ± 0.45 
Median 5 5 4 4 3 4 4 3 3 3 
Min 3 3 3 2 2 2 2 2 2 2 
Max 5 5 5 4 4 4 4 4 3 3 
Mean rank 4.20 4.20 3.20 1.80 1.60 3.8 3.8 2.9 2.1 2.4 
P value Chi square = 99.79, p < 0.0001* Chi square = 61.5,  p < 0.0001* 
Combine Mean ± SD 4.2 ± 0.84 3.4 ± 0.55 2.4 ± 0.55 2 ± 1.0 1.6 ± 0.44 3.2 ± 0.84 2.8 ± 0.45 2.4 ± 0.89 1.6 ± 0.55 0.6 ± 0.15 
Median 4 3 2 2 2 3 3 3 2 1 
 Min 3 3 2 1 0 2 2 1 1 0 
 Max 5 4 3 3 3 4 3 3 2 1 
 Mean rank 4.9 4.1 2.5 2 1.5 4.6 4 3.3 2 1.1 
 P value Chi square = 112.18, p < 0.0001* Chi square = 110.13, p < 0.0001* 
Significance level p<0.05; *=significant; ns=non-significant. 
Comparing the sign and pain scores at 
baseline and throughout the study at 1, 2, 3 and 4 
weeks within the same group using Friedman test it 
was revealed that a significant difference in each of 
the 3 groups was obtained (Table 3). 
Regarding the sign scores, the greatest 
percentage of change was noted in the combined 
group, whereas the least percent of change was 
recorded in the steroid group. ANOVA test revealed 
that the difference was statistically significant 
(p<0.0001). Tukey’s post hoc test revealed a 
significant difference between every 2 groups (Table 
4). 
Regarding the pain scores, the greatest 
percentage of change was also noted in the combined 
group, whereas the least percentage of change was 
recorded in the ozone group. ANOVA test revealed 
that the difference was statistically significant 
(p<0.0001). Tukey’s post hoc test revealed no 
significant difference between combined, ozone and 
steroid groups (Table 4). 
Table 4: Comparison between groups regarding sign and pain 
scores percentage of change after treatment (ANOVA test) 
Groups % of the change in Sign score % of the change in Pain score 
Mean ± SD Mean ± SD 
Steroid -22.00
c
 ± 2.74 -78.33
a
 ± 12.64 
Ozone -29.33
b
 ± 8.94 -15.00
b 
± 4.69 
Combined -65.00
a 
± 21.45 -83.33
a
 ± 15.59 
F value 92.78 327.536 
p-value <0.0001* <0.0001* 
Tukey’s post hoc test: means sharing the same superscript letter are not significantly different 
Significance level p<0.05; *=significant; ns=non-significant. 
 
Improvement of OLP lesion following 
combined ozone and steroid therapy reported healing 
in the area treated as shown in Figure 2.  
 
 
Discussion  
 
Complete curative management of OLP has 
not yet accomplished because of the chronic and 
refractory nature of the disease [16]. 
The inflammatory and immunologically 
mediated characters of OLP recommended the use of 
corticosteroids; thus topical, intralesional and systemic 
steroids are utilised. Corticosteroids are accepted as a 
palliative and relieving therapy rather than a 
therapeutic agent in the management of OLP [17] 
[18].  
 
Figure 2: Improvement of OLP lesion following combined ozone and 
steroid therapy 
 
In addition to corticosteroids, various 
interventions have been presented for management of 
OLP including immunosuppressants (e.g., 
cyclosporine and tacrolimus), topical or systemic 
retinoids, and oral metronidazole. Also, various herbal 
extracts and laser therapy are among the different 
modalities that have been introduced in the 
management of OLP. All remedies have been applied 
in an attempt to improve OLP lesion and associated 
symptoms such as pain and burning sensation [19] 
[20]. 
Topical steroid is considered the first-line 
effective treatment option for erosive-atrophic OLP 
with promising outcomes as regarding pain and 
soreness relief. Several patients encountered various 
adverse effects with this treatment modality including 
candidal overgrowth and mucosal atrophy as 
previously documented [21] [22] [23]. 
Thus, various randomised clinical trials 
suggested diverse treatment options in addition to 
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topical steroids as a combination or as a substitute for 
steroids [24]. 
New non-medication treatment modalities are 
suggested including ozone. Ozone has been utilised 
effectively for the treatment of different disorders for 
over 100 years. Its special properties incorporate 
immuno-stimulant, pain relieving, antihypnotic, 
detoxicating, antimicrobial, bio-energetic and 
biosynthetic activities with powerful wound healing 
properties. Ozone is capable of interacting with blood 
constituents (erythrocytes, platelets, leukocytes, and 
endothelial cells) and induces oxygen metabolism, cell 
energy and immuno-modulatory changes. Ozone can 
enhance the antioxidant defence system and 
stimulate the microcirculation in tissues [23]. 
The findings of this study revealed that the 
sign scores decreased after treatment within the 3 
groups where this decrease was statistically 
significant. This is by the results demonstrated by 
Kazancioglu and Erisen, 2015 [21].  
The outcomes of this study also showed that 
pain scores decreased after treatment within each 
group. This difference was statistically significant both 
in the steroid and combined groups. However, this 
difference was not statistically significant in the ozone 
group. This is against the findings previously 
conducted. This may be due to the difference in the 
ozone generator used and follow up periods between 
the studies [21].  
Also, the results of this contemplate showed 
that topical ozone application prevented the candidal 
overgrowth in ozone and combined groups. This was 
in line with a study conducted by Arita et al., 2015 who 
concluded that the use of ozonated water might be 
useful in oral candidal treatment due to the strong and 
effective antifungal properties of ozone [24].  
The bactericidal, fungicidal, and virucidal 
properties of ozone may be explained on the basis of 
its powerful oxidising ability with the creation of free 
radicals and direct destruction of almost all pathogenic 
microorganisms. Adding to that, ozone favours tissue 
healing and increases blood perfusion. It can improve 
blood flow and immunological reaction. Ozone affects 
both the cellular and humoral immune responses, 
oxidises poisons making their discharge simpler, 
empowers the creation of immunocompetent cells and 
immunoglobulins, enhances phagocytosis capacity of 
macrophages, which closures inflammation and fasten 
tissue healing. Besides, ozone improves the oxygen 
conveying limit of blood causing better metabolism of 
inflamed tissues cells and more usage of energy using 
actuation of aerobic pathways of metabolism. What's 
more, oxidant action of ozone helps protein production 
and upgrades cell ribosomes and mitochondria. Thus, 
cell action and recovery possibilities will be enhanced 
with the improvement of the tissue healing process. 
This might explains the study outcomes reporting the 
greatest percentage of change which was noted in the 
combined group in both sign and pain scores [24].  
Considering the various beneficial effects 
obtained from the reported data in this study using the 
combined ozone and steroid therapy a new promising 
adjunct therapy might be presented for management 
of OLP. However, with the limitations of this study 
many more long-term studies are needed to 
substantiate the use of this combination.  
Accordingly, it could be concluded that topical 
ozone can be combined with topical steroid therapy as 
a new more effective and safe treatment modality for 
symptomatic OLP. 
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